Latest News

(UroToday.com) The detection of recurrence and salvage treatment options after primary treatment for prostate cancer session at the European Association of Urology 2021 annual meeting included a presentation by Dr. Daniele Robesti discussing 68Ga-PSMA PET/CT for recurrent prostate cancer after radical prostatectomy. Use of 68Ga-PSMA PET/CT is recommended for prostate cancer re-staging in patients with either PSA […]

(UroToday.com) At the controversies in Onco-Urology session of the European Association of Urology 2021 annual meeting, Dr. Alberto Bossi discussed radiotherapy after radical prostatectomy in the PSMA-PET era. Adjuvant radiotherapy is defined as immediate postoperative radiation in the case of extraprostatic extension, positive margins, seminal vesicle infiltration, high Gleason score, or pN+ disease. Salvage radiotherapy is […]

(UroToday.com) At the European Association of Urology 2021 Annual Meeting’s controversies in Onco-Urology session, Dr. J. Alfred Witjes discussed that there is a role for radical cystectomy in cT0 disease after neoadjuvant chemotherapy. Dr. Witjes notes that chemotherapy is insufficient as curative therapy in bladder cancer, with the AUA guidelines stating that clinicians should perform radical […]

(UroToday.com) At the European Association of Urology 2021 Meeting’s controversies in Onco-Urology session, Dr. Alexandra Masson-Lecomte discussed that there is no role for radical cystectomy in cT0 disease after neoadjuvant chemotherapy.

(UroToday.com) The Controversies in Onco-Urology session at the EAU 2021 annual meeting included a presentation by Dr. Nadine Houede who discussed the adjuvant approach to the optimal timing of perioperative systemic therapy for high-risk upper tract urothelial carcinoma. Dr. Houede notes that upper tract urothelial carcinoma makes up 5% of urothelial carcinomas, with 50-60% comprising […]

Typically, the Annual EAU Congress is also the occasion for the annual General Assembly, where new positions within the EAU are approved and other matters voted on by the membership. Because of the last-minute postponement and decision to hold a virtual congress in 2020, this was not possible at EAU20. At EAU21 however, a virtual […]

Awardees recognized for novel approaches to fuel breakthroughs in bladder cancer research San Francisco, CA (UroToday.com) — The Bladder Cancer Advocacy Network (BCAN) announced the two recipients of its prestigious Bladder Cancer Research Innovation Award. This is the first year in which two awards have been granted. This year’s awardees are Weiguo Cui, PhD, an […]

Benign prostatic hyperplasia (BPH) is an age-related disease that is frequently associated with chronic prostatic inflammation. In previous studies, we detected the presence of PSA protein in the stroma of BPH nodules and down-regulation of junction proteins E-cadherin and claudin-1.

To validate the predictive and prognostic role of the De Ritis ratio in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy in a large multi-institutional cohort.

Surveillance is now the preferred treatment strategy for patients with stage 1A/1B seminoma as reflected by the National Comprehensive Cancer Network guidelines. In this study, we aimed to describe trends in adjuvant management strategy for stage 1A/B seminoma from 2004 to 2016 using the National Cancer Database.